🔍
HMG-1 transgenic mouse
Case ID:
C04452
Report of Invention:
5/3/2004
Web Published:
10/7/2014
C04452: HMG-1 transgenic mouse
Technical Details:
The HMG-I/Y gene is overexpressed in human cancer, although a direct role for this gene in transformation had not been established. JHU researchers have generated transgenic mice with HMG-I targeted to lymphoid cells. All 7 informative founder HMG-I mice developed aggressive lymphoma by a mean age of 4.8 months. Their tumors express T cell markers and are transplantable. These results show that HMG-I functions as an oncogene and suggest that it contributes to the pathogenesis of leukemia and other cancers with increased HMG-I expression.
Looking for Partners:
This transgenic mouse can be used as a model for human leukemia and lymphoma in order to identify pathways involved in transformation by HMG-I and new therapies for cancers associated with HMG-I overexpression.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://jhu.technologypublisher.com/technology/16338
Inventors:
Category(s):
Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Research Tools > Animal Models, Technology Classifications > Research Tools,
Get custom alerts for techs in these categories/from these inventors:
Subscribe for JHTV Updates
For Information, Contact:
Vera Sampels
vsampel2@jhu.edu
410-614-0300
Save This Technology:
Bookmark this page
Download as PDF
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum